Clinical Trial Update: the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of eN-Lac® capsules (Lactobacillus paracasei GMNL-32) in children with perennial allergic rhinitis; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• eN-Lac® Capsules (Lactobacillus paracasei GMNL-32)

Snippet

Sponsor: GenMont Biotech Incorporation | Conditions: Perennial Allergic Rhinitis, Probiotics | Phase 3 | Status: COMPLETED